ALSTON & BIRD LLP
Lobbying for BIOMERIEUX, INC. · Global in vitro diagnostics company.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.